TarsheenKaurSethiMDMSCI

Hematology • New Haven, CT

Hematologic Oncology

Assistant Professor of Medicine

Join to view full profile

Dr. Sethi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sethi's full profile

Already have an account?

Office
20 york street
New Haven, CT 06510

Summary

Dr. Tarsheen Sethi is a hematologist in New Haven CT and is affiliated with Yale University School of Medicine. She received her medical degree from Maulana Azad Medical College and has been in practice 12 years. She specializes in hematologic oncology, particularly lymphomas

Education & Training

Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2014 - 2018
Stanford Health CarePost-Doctoral Fellowship, 2013 - 2014
University of Louisville School of MedicineResidency, Internal Medicine, 2010 - 2013
Maulana Azad Medical CollegeClass of 2005

Certifications & Licensure

CA State Medical License 2012 - 2026
CT State Medical License 2020 - 2025
TN State Medical License 2018 - 2020
IN State Medical License Active through 2013
KY State Medical License Active through 2013
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

44 citations
Radon and lung cancer.
Tarsheen K. Sethi, Moataz N. El-Ghamry, Goetz H. Kloecker
Clinical Advances in Hematology & Oncology. 2012-03-01
12 citations
Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma.
Tarsheen K. Sethi, Van T Nguyen, Shaoying Li, David S. Morgan, John P. Greer
Therapeutic Advances in Hematology. 2017-01-01
12 citations
Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics.
Savanah D Gisriel, Ji Yuan, Ryan C Braunberger, Danielle L V Maracaja, Xueyan Chen
Modern Pathology. 2022-10-01

Abstracts/Posters

Impact of Novel Agents on Outcomes of Patients with Classical Hodgkin Lymphoma and Primary Treatment Failure
Tarsheen K. Sethi, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/7/2019

Lectures

Combination of Nivolumab, Lenalidomide and Rituximab in Relapsed/Refractory Non-Germinal Center Diffuse Large B Cell Lymphoma: Results from a Dose-Escalation Cohort
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

External Links

Google scholarhttps://scholar.google.com/citations?user=cLQzwtEAAAAJ&hl=en&oi=ao
Vanderbilthttps://labnodes.vanderbilt.edu/member/profile/id/12217